$迈威生物-B(02_老虎社区_美港股上老虎

穿越天
04-27

$迈威生物-B(02493)$ 深夜复盘迈威2025年报，营收6.63亿同比暴增231%，BD授权收入4.09亿暴涨642%，这造血能力在创新药里真不多见。9MW2821三项三期临床今年期中分析，pre-NDA在即，兄弟们这进度国内第一全球第二，拿住了

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":558047336289672,"tweetId":"558047336289672","gmtCreate":1777273735712,"gmtModify":1777273738068,"author":{"id":4129866840184330,"idStr":"4129866840184330","authorId":4129866840184330,"authorIdStr":"4129866840184330","name":"穿越天","avatar":"https://static.tigerbbs.com/e2b99e3824acc0961e784d70e0d77715","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> 深夜复盘迈威2025年报，营收6.63亿同比暴增231%，BD授权收入4.09亿暴涨642%，这造血能力在创新药里真不多见。9MW2821三项三期临床今年期中分析，pre-NDA在即，兄弟们这进度国内第一全球第二，拿住了</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> 深夜复盘迈威2025年报，营收6.63亿同比暴增231%，BD授权收入4.09亿暴涨642%，这造血能力在创新药里真不多见。9MW2821三项三期临床今年期中分析，pre-NDA在即，兄弟们这进度国内第一全球第二，拿住了</body></html>","text":"$迈威生物-B(02493)$ 深夜复盘迈威2025年报，营收6.63亿同比暴增231%，BD授权收入4.09亿暴涨642%，这造血能力在创新药里真不多见。9MW2821三项三期临床今年期中分析，pre-NDA在即，兄弟们这进度国内第一全球第二，拿住了","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/558047336289672","repostId":0,"isVote":1,"tweetType":1,"viewCount":1149,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02493","688062"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":196,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}